The psychological and psychiatric effects of rIL-2 therapy: A controlled clinical trial

Psycho-Oncology

Volumn 6, Issue 4, 1997, Pages 290-301

  Walker, Leslie Gresson ^a   Walker, Mary Birnie ^a   Heys, Stephen Darrell ^a   Lolley, Jane ^a   Wesnes, Keith ^b   Eremin, Oleg ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Cognitive Drug Research ^*

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; RECOMBINANT INTERLEUKIN 2;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; MALE; MENTAL HEALTH; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SLEEP DEPRIVATION;

ANTIMETABOLITES, ANTINEOPLASTIC; COGNITION DISORDERS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; CONFUSION; DEPRESSIVE DISORDER; FEMALE; FLUOROURACIL; HUMANS; INTERLEUKIN-2; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RECOMBINANT PROTEINS;

EID: 0031442482     PISSN: 10579249     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1611(199712)6:4<290::AID-PON283>3.0.CO;2-G     Document Type: Article

References (31)

1. Ader, R., Felton, D.L. and Cohen, N. (1991) Psychoneuroimmunology. Academic Press, San Diego.
2. R. American Psychiatric Press, Inc., Washington DC.
3. Army Individual Test Battery Manual (1944) War Department, Washington DC.
4. Benton, A.L. (1974) Revised Visual Retention Test: Clinical and Experimental Applications. The Psychological Corporation, New York.
5. Black, P.H. (1994a) Immune system-central nervous system interactions: psychoneuroendocrinology of stress and its immune consequences. Antimicrob. Agents Chemother. 38, 1-6.
6. Black, P.H. (1994b) Central nervous system-immune system interactions: effect and immunomodulatory consequences of immune system mediators in brain. Antimicrob. Agents Chemother. 38, 7-12.
7. Caraceni, A., Martini, C., Belli, F., Mascheroni, L., Rovoltini, L., Arienti, F. and Cascinelli, N. (1992) Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration. Eur. J. Cancer, 29A, 1266-1269.
8. Deehan, D.J., Heys, S.D., Simpson, W.G., Herriot, R., Broom, J. and Eremin, O. (1994) Correlation of serum cytokine and acute phase reactant levels with alterations in weight and serum albumin in patients receiving immunotherapy with recombinant IL-2. Clin. Exp. Immunol. 95, 366-372.
9. Denicoff, K.D., Durkin, T.M., Lotze, M.T., Quinlan, P.E., Davis, C.L., Listwak, S.J., Rosenberg, S.A. and Rubinow, D.R. (1989) The neuroendocrine effects of interleukin-2 treatment. J. Clin. Endocrinol. Metab., 69, 402-410.
10. Denicoff, K.D., Ribinow, D.R., Papa, M.Z., Simpson, C., Seipp, C.A., Lotze, M.T. et al. (1987) The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann. Intern. Med., 107, 293-300.
11. Folstein, M., Folstein, S. and McHugh, PR. (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiat. Res., 12, 189-198.
12. Greer, S. and Watson, M. (1987) Mental adjustment to cancer: its measurement and prognostic significance. Cancer Surv., 6, 439-453.
13. de Haes, J.C.J.M., van Knippenberg, F.C.E. and Neijt, J.P. (1990) Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br. J. Cancer, 62, 1034-1038.
14. Heys, S.D., Franks, C.R. and Eremin, O. (1993) Interleukin-2 therapy: current role in surgical oncological practice. Br. J. Surg., 80, 155-162.
15. Heys, S.D., Deehan, D.J. and Eremin, O. (1994) Interleukin 2 treatment in colorectal cancer: current results and future prospects. Eur. J. Surg. Oncol. 20, 622-1529.
16. Heys, S.D., Eremin, O., Ruggeri, E.M., Pein, H., Rainer, H., Oskam, R., de Peuter, R.A., Palmer, P.A. and Franks, C.R. (1995) A phase III study of recombinant interleukin-2, 5-fluorouracul and leucovorin in patients with unresectable or metastatic colorectal carcinoma. Eur. J. Cancer, 31A, 19-25.
17. Heys, S.D., Gough, D.B., and Eremin, O. (1996) Immunotherapy with interleukin-2: recent developments. Exp. Opin. Invest. Drugs, 5, 269-288.
18. Johnson, V.C., Walker, L.G., Heys, S.D., Whiting, P.H. and Eremin O. (1996) Can relaxation training modify the immune response to stress, and is hypnotisability relevant? Contemp. Hypnosis, 13, 100-108.
19. Lorr, M. and McNair, D.M. (1984) Manual of the Profile of Mood States. Educational and Industrial Testing Service, San Diego.
20. McMillan, D.N., Kernohan, N.M., Flett, M.E., Kelly, P., Heys, S.D., Sewell, H.F., Walker, F. and Eremin, O. (1995). Interleukin 2 and interleukin 2 receptors are present in human solid tumour cells in situ and in solid tumour cell lines in vitro: evidence for a direct role of the IL-2/IL-2R system in the regulation of tumour cell proliferation. Int. J. Cancer, 60, 766-772.
21. Meyers, C.A. and Valentine, A.D. (1995) Neurological and psychiatric adverse effects of immunological therapy. CNS Drugs, 3, 56-68.
22. Moertel, G.G. (1986) On lymphokines, cytokines, and breakthroughs. JAMA, 256, 3141.
23. Saris, S.C., Patronas, NJ., Rosenberg, S.A. et al. (1988) The effect of intravenous interleukin-2 on brain water content. J. Neurosurg., 71, 169-174.
24. Smith, M.J. and Khayat, D. (1992) Residual acute confusional and hallucinatory syndromes induced by Interleukin-2 and α-Interferon treatment. Psycho-OncoL, 1, 115-118.
25. Smith, M.J., Mouawad, R., Vuillemin, E., Benhammouda, C., Soubrane, C. and Khayat, D. (1994) Psychological side effects induced by interleukin-2/ainterferon treatment. Psycho-Oncol., 3, 289-298.
26. Walker, L.G. and Eremin, O. (1995) Psychoneuroimmunology: a new fad or the fifth cancer treatment modality? Am. J. Surg., 170, 2-4.
27. Walker, L.G., Wesnes, K.P., Keys, S.D., Walker, M.B., Lolley, J. and Eremin, O. (1996) The cognitive effects of recombinant Interleukin-2 (rIL-2) therapy: a controlled clinical trial using computerised assessments. Eur. J. Cancer, 32A, 2275-2283.
28. Watson, M. and Greer, S. (1983) Development of a questionnaire measure of emotional control. J. Psychosom. Res., 27, 299-305.
29. Wechsler, D. (1955) Manual of the Wechsler Adult Intelligence Scale. Psychological Corporation, New York.
30. Wesnes, K.P., Walker, L.G., Walker, M.B., Heys, S.D., White, L., Warren, R. and Eremin, O. (1997). What does a weekend 'on call' in a surgical unit do to cognitive performance and mood?' Brit. J. Surg, 84, 493-495.
31. Zigmond, A.S. and Snaith, R.P. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiat. Scand., 67, 361-370.